What is Monogram Technologies Operating Cash Flow per Share?
Monogram Technologies's operating cash flow per share for the
three
months ended in Mar. 2024 was $-0.12.
Monogram Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.58.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -51.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -118.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Monogram Technologies's Operating Cash Flow per Share or its related term are showing as below:
MGRM'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -209.7 Med: -103.05 Max: -51.1
Current: -51.1
During the past 7 years, Monogram Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was -51.10% per year. The lowest was -209.70% per year. And the median was -103.05% per year.
MGRM's 3-Year OCF Growth Rate is ranked worse than 91.39% of 685
companies
in the Medical Devices & Instruments industry
Industry Median: 2.6
vs MGRM: -51.10
Monogram Technologies Operating Cash Flow per Share Historical Data
The historical data trend for Monogram Technologies's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Monogram Technologies Operating Cash Flow per Share Chart
Competitive Comparison of Monogram Technologies's Operating Cash Flow per Share
For the Medical Devices subindustry, Monogram Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monogram Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Monogram Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Monogram Technologies's Price-to-Operating-Cash-Flow falls into.
Monogram Technologies Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Monogram Technologies's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.58
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monogram Technologies Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Monogram Technologies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Monogram Technologies (Monogram Technologies) Business Description
Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MGRM has been successfully added to your 